Terms: = Colorectal cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Prognosis
57 results:
1. ezh2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M; Nazdari N; Gholamiyan G; Paskeh MDA; Jafari AM; Nemati F; Khodaei E; Abyari G; Behdadfar N; Raei B; Raesi R; Nabavi N; Hu P; Rashidi M; Taheriazam A; Entezari M
Pathol Res Pract; 2024 Jan; 253():154988. PubMed ID: 38118215
[TBL] [Abstract] [Full Text] [Related]
2. Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies.
Firouzjaei AA; Aghaee-Bakhtiari SH; Tafti A; Sharifi K; Abadi MHJN; Rezaei S; Mohammadi-Yeganeh S
Cell Biochem Funct; 2023 Dec; 41(8):1488-1502. PubMed ID: 38014635
[TBL] [Abstract] [Full Text] [Related]
3. TRIM29 promotes the progression of colorectal cancer by suppressing ezh2 degradation.
Chen Y; Ma J; Zhang M
Exp Biol Med (Maywood); 2023 Sep; 248(18):1527-1536. PubMed ID: 37837384
[TBL] [Abstract] [Full Text] [Related]
4. ezh2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.
Chen J; Hong JH; Huang Y; Liu S; Yin J; Deng P; Sun Y; Yu Z; Zeng X; Xiao R; Chan JY; Guan P; Wang Y; Wang P; Liu L; Wen S; Yu Q; Ong CK; Teh BT; Xiong Y; Tan J
Mol Cancer; 2023 May; 22(1):85. PubMed ID: 37210576
[TBL] [Abstract] [Full Text] [Related]
5. PROX1-mediated epigenetic silencing of
Gan L; Li Q; Nie W; Zhang Y; Jiang H; Tan C; Zhang L; Zhang J; Li Q; Hou P; Yuan Y; Sun X; Liu D; Sheng W; Liu T; Xu M; Guo W
Int J Biol Sci; 2023; 19(1):50-65. PubMed ID: 36594098
[TBL] [Abstract] [Full Text] [Related]
6. Differential expression of HNF1A and HNF1A-AS1 in colon cancer cells.
Sepehri Z; Banerjee A; Vizeacoumar FS; Freywald A; Vizeacoumar FJ; Dolinsky VW; Davie JR
IUBMB Life; 2022 Jun; 74(6):496-507. PubMed ID: 35184384
[TBL] [Abstract] [Full Text] [Related]
7. CDC42 as an epigenetic regulator of ID4 in triple-negative breast tumors.
Nasif D; Real S; Roqué M; Branham MT
Breast Cancer; 2022 May; 29(3):562-573. PubMed ID: 35094293
[TBL] [Abstract] [Full Text] [Related]
8. miR-1253, a novel tumor suppressor gene in colon cancer, is associated with poor patients prognosis.
Yang D; Zhang D
Clin Exp Med; 2021 Nov; 21(4):563-571. PubMed ID: 33837882
[TBL] [Abstract] [Full Text] [Related]
9. PRMT5 functionally associates with ezh2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
10. Long non-coding RNA Lnc-LALC facilitates colorectal cancer liver metastasis via epigenetically silencing LZTS1.
Zhang C; Wang L; Jin C; Zhou J; Peng C; Wang Y; Xu Z; Zhang D; Huang Y; Zhang Y; Ji D; Peng W; Jin K; Tang J; Feng Y; Sun Y
Cell Death Dis; 2021 Feb; 12(2):224. PubMed ID: 33637680
[TBL] [Abstract] [Full Text] [Related]
11. MiR-133b inhibits colorectal cancer metastasis via lncRNA-LUCAT1.
Ma M; Li L; Long F; Xiao H; Lu M; Lin C
Future Oncol; 2021 Mar; 17(9):1013-1023. PubMed ID: 33541136
[No Abstract] [Full Text] [Related]
12. LINC00538 promotes the progression of colon cancer through inhibiting NKD2 expression.
Tang H; Dou Y; Meng Y; Lu Q; Liang L; Luo Y
J BUON; 2020; 25(6):2657-2664. PubMed ID: 33455110
[TBL] [Abstract] [Full Text] [Related]
13. HDAC2 promotes the EMT of colorectal cancer cells and via the modular scaffold function of ENSG00000274093.1.
Qi ZP; Yalikong A; Zhang JW; Cai SL; Li B; Di S; Lv ZT; Xu EP; Zhong YS; Zhou PH
J Cell Mol Med; 2021 Jan; 25(2):1190-1197. PubMed ID: 33325150
[TBL] [Abstract] [Full Text] [Related]
14. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation.
Jin L; Cai Q; Wang S; Wang S; Wang J; Quan Z
Cell Death Dis; 2020 Oct; 11(10):871. PubMed ID: 33067424
[TBL] [Abstract] [Full Text] [Related]
15. Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-κB/YY1 axis.
Liu J; Zhan Y; Wang J; Wang J; Guo J; Kong D
Mol Oncol; 2020 Dec; 14(12):3211-3233. PubMed ID: 33040438
[TBL] [Abstract] [Full Text] [Related]
16. Downregulated LINC00628 aggravates the progression of colorectal cancer via inhibiting p57 level.
Zhang MC; Zhang L; Zhang MQ; Yang GX; Wang FZ; Ding P
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1763-1770. PubMed ID: 32141544
[TBL] [Abstract] [Full Text] [Related]
17. Long noncoding RNA LINC00630 promotes radio-resistance by regulating BEX1 gene methylation in colorectal cancer cells.
Liu F; Huang W; Hong J; Cai C; Zhang W; Zhang J; Kang Z
IUBMB Life; 2020 Jul; 72(7):1404-1414. PubMed ID: 32119177
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Value of TWIST1 and ezh2 Expression in Colon cancer.
Abdel Raouf SM; Ibrahim TR; Abdelaziz LA; Farid MI; Mohamed SY
J Gastrointest Cancer; 2021 Mar; 52(1):90-98. PubMed ID: 31823218
[TBL] [Abstract] [Full Text] [Related]
19. A TGF-β-MTA1-SOX4-ezh2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T
Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272
[TBL] [Abstract] [Full Text] [Related]
20. Enhancer of Zeste Homolog 2 in colorectal cancer Development and Progression.
Bremer SCB; Conradi LC; Mechie NC; Amanzada A; Mavropoulou E; Kitz J; Ghadimi M; Ellenrieder V; Ströbel P; Hessmann E; Gaedcke J; Bohnenberger H
Digestion; 2021; 102(2):227-235. PubMed ID: 31694013
[TBL] [Abstract] [Full Text] [Related]
[Next]
